U.S. pharma giant copyright scrapped two experimental weight loss drugs final 12 months—a once-each day tablet, lotiglipron, on account of elevated liver enzymes and a 2 times-every day pill, danuglipron, as a consequence of powerful Unwanted effects—but CEO Albert Bourla has stated the company is set to “Enjoy and win” inside the obesity R